Preview of the 93rd American Thyroid Association Annual Meeting
Thyroid. 2024 May 2. doi: 10.1089/thy.2024.0185. Online ahead of print.ABSTRACTN/A.PMID:38698668 | DOI:10.1089/thy.2024.0185 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - May 3, 2024 Category: Endocrinology Authors: Meredith D Hartley Whitney Goldner Source Type: research

Bryan McIver, MD PhD FRCP(Edin) (January 4, 1960-December 16, 2023)
Thyroid. 2024 May 3. doi: 10.1089/thy.2024.87321.inmem. Online ahead of print.NO ABSTRACTPMID:38700709 | DOI:10.1089/thy.2024.87321.inmem (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - May 3, 2024 Category: Endocrinology Source Type: research

Preview of the 93rd American Thyroid Association Annual Meeting
Thyroid. 2024 May 2. doi: 10.1089/thy.2024.0185. Online ahead of print.ABSTRACTN/A.PMID:38698668 | DOI:10.1089/thy.2024.0185 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - May 3, 2024 Category: Endocrinology Authors: Meredith D Hartley Whitney Goldner Source Type: research

Bryan McIver, MD PhD FRCP(Edin) (January 4, 1960-December 16, 2023)
Thyroid. 2024 May 3. doi: 10.1089/thy.2024.87321.inmem. Online ahead of print.NO ABSTRACTPMID:38700709 | DOI:10.1089/thy.2024.87321.inmem (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - May 3, 2024 Category: Endocrinology Source Type: research

Preview of the 93rd American Thyroid Association Annual Meeting
Thyroid. 2024 May 2. doi: 10.1089/thy.2024.0185. Online ahead of print.ABSTRACTN/A.PMID:38698668 | DOI:10.1089/thy.2024.0185 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - May 3, 2024 Category: Endocrinology Authors: Meredith D Hartley Whitney Goldner Source Type: research

Bryan McIver, MD PhD FRCP(Edin) (January 4, 1960-December 16, 2023)
Thyroid. 2024 May 3. doi: 10.1089/thy.2024.87321.inmem. Online ahead of print.NO ABSTRACTPMID:38700709 | DOI:10.1089/thy.2024.87321.inmem (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - May 3, 2024 Category: Endocrinology Source Type: research

Levothyroxine treatment in pregnant women with thyroid stimulating hormone levels ranging between 2.5 and 10 mIU/L: A propensity score matched analysis
CONCLUSION: LT-4 treatment was significantly associated with a lower risk of pregnancy loss and a higher risk of small-for-gestational-age infants in pregnant women with TSH levels of 2.5-10 mIU/L. An increased risk of preterm birth was observed in the LT-4-treated group among TPOAb-positive participants with TSH levels of 2.5-4.0 mIU/L.PMID:38666684 | DOI:10.1089/thy.2023.0662 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - April 26, 2024 Category: Endocrinology Authors: Shen Gao Xueran Wang Rong Zhao Yuchen Cui Shaofei Su Enjie Zhang Jianhui Liu Shuanghua Xie Yue Zhang Yuxi Yang Kaikun Huang Minhui Hu Wentao Yue Ruixia Liu Chenghong Yin Source Type: research

Macrophage-induced carboxypeptidase A4 promotes the progression of anaplastic thyroid cancer
CONCLUSIONS: Our data suggest that CPA4 stimulates the progression of thyroid cancer by mediating between M2 macrophages and ATC cells. CPA4 can be a new therapeutic target for the treatment of patients with ATC.PMID:38666696 | DOI:10.1089/thy.2023.0427 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - April 26, 2024 Category: Endocrinology Authors: Yeon-Sook Choi Min Ji Jeon Woo Kyung Lee Doolittle Dong Eun Song Kyunggon Kim Won Bae Kim Won Gu Kim Source Type: research

Levothyroxine treatment in pregnant women with thyroid stimulating hormone levels ranging between 2.5 and 10 mIU/L: A propensity score matched analysis
CONCLUSION: LT-4 treatment was significantly associated with a lower risk of pregnancy loss and a higher risk of small-for-gestational-age infants in pregnant women with TSH levels of 2.5-10 mIU/L. An increased risk of preterm birth was observed in the LT-4-treated group among TPOAb-positive participants with TSH levels of 2.5-4.0 mIU/L.PMID:38666684 | DOI:10.1089/thy.2023.0662 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - April 26, 2024 Category: Endocrinology Authors: Shen Gao Xueran Wang Rong Zhao Yuchen Cui Shaofei Su Enjie Zhang Jianhui Liu Shuanghua Xie Yue Zhang Yuxi Yang Kaikun Huang Minhui Hu Wentao Yue Ruixia Liu Chenghong Yin Source Type: research

Macrophage-induced carboxypeptidase A4 promotes the progression of anaplastic thyroid cancer
CONCLUSIONS: Our data suggest that CPA4 stimulates the progression of thyroid cancer by mediating between M2 macrophages and ATC cells. CPA4 can be a new therapeutic target for the treatment of patients with ATC.PMID:38666696 | DOI:10.1089/thy.2023.0427 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - April 26, 2024 Category: Endocrinology Authors: Yeon-Sook Choi Min Ji Jeon Woo Kyung Lee Doolittle Dong Eun Song Kyunggon Kim Won Bae Kim Won Gu Kim Source Type: research

Levothyroxine treatment in pregnant women with thyroid stimulating hormone levels ranging between 2.5 and 10 mIU/L: A propensity score matched analysis
CONCLUSION: LT-4 treatment was significantly associated with a lower risk of pregnancy loss and a higher risk of small-for-gestational-age infants in pregnant women with TSH levels of 2.5-10 mIU/L. An increased risk of preterm birth was observed in the LT-4-treated group among TPOAb-positive participants with TSH levels of 2.5-4.0 mIU/L.PMID:38666684 | DOI:10.1089/thy.2023.0662 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - April 26, 2024 Category: Endocrinology Authors: Shen Gao Xueran Wang Rong Zhao Yuchen Cui Shaofei Su Enjie Zhang Jianhui Liu Shuanghua Xie Yue Zhang Yuxi Yang Kaikun Huang Minhui Hu Wentao Yue Ruixia Liu Chenghong Yin Source Type: research

Macrophage-induced carboxypeptidase A4 promotes the progression of anaplastic thyroid cancer
CONCLUSIONS: Our data suggest that CPA4 stimulates the progression of thyroid cancer by mediating between M2 macrophages and ATC cells. CPA4 can be a new therapeutic target for the treatment of patients with ATC.PMID:38666696 | DOI:10.1089/thy.2023.0427 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - April 26, 2024 Category: Endocrinology Authors: Yeon-Sook Choi Min Ji Jeon Woo Kyung Lee Doolittle Dong Eun Song Kyunggon Kim Won Bae Kim Won Gu Kim Source Type: research

Levothyroxine treatment in pregnant women with thyroid stimulating hormone levels ranging between 2.5 and 10 mIU/L: A propensity score matched analysis
CONCLUSION: LT-4 treatment was significantly associated with a lower risk of pregnancy loss and a higher risk of small-for-gestational-age infants in pregnant women with TSH levels of 2.5-10 mIU/L. An increased risk of preterm birth was observed in the LT-4-treated group among TPOAb-positive participants with TSH levels of 2.5-4.0 mIU/L.PMID:38666684 | DOI:10.1089/thy.2023.0662 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - April 26, 2024 Category: Endocrinology Authors: Shen Gao Xueran Wang Rong Zhao Yuchen Cui Shaofei Su Enjie Zhang Jianhui Liu Shuanghua Xie Yue Zhang Yuxi Yang Kaikun Huang Minhui Hu Wentao Yue Ruixia Liu Chenghong Yin Source Type: research

Macrophage-induced carboxypeptidase A4 promotes the progression of anaplastic thyroid cancer
CONCLUSIONS: Our data suggest that CPA4 stimulates the progression of thyroid cancer by mediating between M2 macrophages and ATC cells. CPA4 can be a new therapeutic target for the treatment of patients with ATC.PMID:38666696 | DOI:10.1089/thy.2023.0427 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - April 26, 2024 Category: Endocrinology Authors: Yeon-Sook Choi Min Ji Jeon Woo Kyung Lee Doolittle Dong Eun Song Kyunggon Kim Won Bae Kim Won Gu Kim Source Type: research

Levothyroxine treatment in pregnant women with thyroid stimulating hormone levels ranging between 2.5 and 10 mIU/L: A propensity score matched analysis
CONCLUSION: LT-4 treatment was significantly associated with a lower risk of pregnancy loss and a higher risk of small-for-gestational-age infants in pregnant women with TSH levels of 2.5-10 mIU/L. An increased risk of preterm birth was observed in the LT-4-treated group among TPOAb-positive participants with TSH levels of 2.5-4.0 mIU/L.PMID:38666684 | DOI:10.1089/thy.2023.0662 (Source: Thyroid : official journal of the American Thyroid Association)
Source: Thyroid : official journal of the American Thyroid Association - April 26, 2024 Category: Endocrinology Authors: Shen Gao Xueran Wang Rong Zhao Yuchen Cui Shaofei Su Enjie Zhang Jianhui Liu Shuanghua Xie Yue Zhang Yuxi Yang Kaikun Huang Minhui Hu Wentao Yue Ruixia Liu Chenghong Yin Source Type: research